Dishman Carbogen Amcis is currently trading at Rs. 189.65, up by 10.05 points or 5.60% from its previous closing of Rs. 179.60 on the BSE.
The scrip opened at Rs. 181.10 and has touched a high and low of Rs. 197.40 and Rs. 178.35 respectively. So far 26886 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 2 has touched a 52 week high of Rs. 292.00 on 12-Sep-2018 and a 52 week low of Rs. 159.50 on 22-Aug-2019.
Last one week high and low of the scrip stood at Rs. 197.40 and Rs. 174.00 respectively. The current market cap of the company is Rs. 3060.84 crore.
The promoters holding in the company stood at 61.40%, while Institutions and Non-Institutions held 20.99% and 17.61% respectively.
Drug Controller General of India has approved MDR Tuberculosis (TB) Medicine Bedaquiline Fumarate (BULK) for Dishman Carbogen Amcis for production in India. The company has adequate production facility to produce required quantity of this life saving medicine.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.